India aims to double horticulture output to 700 million tonnes by 2047, focusing on high-yielding, climate-resilient ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® ...

The future of medicine with CRISPR and CAR-T therapy, exploring ethical, societal, and accessibility challenges in healthcare ...

Additionally, Editas Medicine management will participate in the following upcoming investor conferences in March: To access the live webcasts of Editas Medicine’s presentations, please visit the ...

They now run a lab at the Broad Institute in Boston. By 2024 they had created an editor that, in mice, turns off the prion gene in the brain, preventing the disease from taking hold. Next up is making ...

Centurion University hosted the National Conference on “Frontiers in Genetics and Genomics”. The event brought together ...

Plant abiotic stresses such as salinity and drought significantly impede plant growth and agricultural yield globally.

A newly identified version of a gene in the human genome appears to have influenced our capacity for complex speech.

Company expands multiomics portfolio with new roadmap technologies spanning genomics, spatial, single cell, CRISPR, and ...

A human-specific NOVA1 gene variant may have influenced the emergence of spoken language. When introduced into mice, it ...

CRISPR technology, driven by Cas9, redefines gene editing, facilitating targeted DNA modifications that advance genetic ...

Scientists have developed an AI-powered tool that detects 64% of brain abnormalities linked to epilepsy that human radiologists miss.